Evidence map›Paper›PMID 33664871›Full record

ArticleTheranostics2021

Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.

Bing Chen, Yuting Sang, Xiaojin Song, Dong Zhang, Lijuan Wang, Wenjing Zhao, Yiran Liang, Ning Zhang, Qifeng Yang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 2 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 2 syntheses or guidelines pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Bing ChenPathology Tissue Bank, Qilu Hospital of Shandong University.
Yuting SangDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Xiaojin SongDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Dong ZhangDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Lijuan WangPathology Tissue Bank, Qilu Hospital of Shandong University.
Wenjing ZhaoPathology Tissue Bank, Qilu Hospital of Shandong University.
Yiran LiangDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Ning ZhangDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Qifeng YangDepartment of Breast Surgery, General Surgery, Qilu Hospital of Shandong University.
Qilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment contributes to tumor progression and metastasis. Cancer-associated fibroblasts (CAFs) form a major cellular component of the tumor microenvironment. In this study, we further explored the mechanisms underlying the tumor-promoting roles of CAFs.

Indexed as

AnimalsBreast NeoplasmsCancer-Associated FibroblastsCell Line, TumorCell MovementCell ProliferationCoculture TechniquesExosomesFemaleHeterograftsHumansMCF-7 CellsMiceMice, Inbred BALB CMice, NudeMicroRNAsMicroRNAsMIRN500 microRNA, humanUbiquitin ThiolesteraseUSP28 protein, humanbreast cancercancer-associated fibroblastsexosomemiR-500a-5pUSP28

Identifiers

PMID33664871
PMCPMC7914354
OpenAlexW3133365434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.